134 articles

Is Covid-19 Severity Associated With ACE2 Degradation?

in In silico Methods and Artificial Intelligence for Drug Discovery

• Ugo Bastolla
• Patrick Chambers
• David Abia
• Maria-Laura Garcia-Bermejo
• Manuel Fresno

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism

in Neurological Drugs

• Christopher R. Apostol
• Kelsey Bernard
• Parthasaradhireddy Tanguturi
• Gabriella Molnar
• Mitchell J. Bartlett
• Lajos Szabò
• Chenxi Liu
• J. Bryce Ortiz
• Maha Saber
• Katherine R. Giordano

Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient

in Neurological Drugs

• Nuno Jorge Lamas
• Laurent Roybon

Deep Learning Prediction of Adverse Drug Reactions in Drug Discovery Using Open TG–GATEs and FAERS Databases

in In silico Methods and Artificial Intelligence for Drug Discovery

• Attayeb Mohsen
• Lokesh P. Tripathi
• Kenji Mizuguchi

Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges

• Bruno O. Villoutreix

Grand Challenges of Computer-Aided Drug Design: The Road Ahead

in In silico Methods and Artificial Intelligence for Drug Discovery

• José L. Medina-Franco